Literature DB >> 35928247

Considering the impact of patient ethnicity on cystic fibrosis related bone disease.

Mahsa Kabuli1, Amir Reza Akbari2, Benyamin Alam3.   

Abstract

Entities:  

Year:  2022        PMID: 35928247      PMCID: PMC9344016          DOI: 10.1016/j.jcte.2022.100303

Source DB:  PubMed          Journal:  J Clin Transl Endocrinol        ISSN: 2214-6237


× No keyword cloud information.
Dear editor, We found the article “Bone accrual and structural changes over one year in youth with cystic fibrosis” by Rosara M.Bass et al [1] to be of great interest. The study investigated bone changes over one year in individuals aged 5–18 with both cystic fibrosis (CF). The aim of this was to see how much bone development in youth and emerging adults contributes to cystic fibrosis related bone disease (CFBD). The study accounted for the following patient demographics: weight, height, age, pubertal status, and gender [1]. Although these are important factors, we believe it is important to consider the impact of patient ethnicity on the development of structural changes in the bone. Several studies across western countries have found that vitamin D deficiencies are more prevalent in ethnic minority groups, including South Asian and Black African-Caribbean populations [2], [3]. This is thought to be due to skin pigmentation being a factor which impacts the levels of vitamin D produced in the skin after sun exposure [2]. Furthermore, vitamin D deficiency is also the most recognised cause of CFBD [4]. Therefore, it is important to recognise the potential impact of ethnicity on changes in bone development in patients with CF. Additionally, it is important to note that studies have demonstrated that CF patients from ethnic minority backgrounds are more likely to experience worse outcomes compared to white patients [5]. For example, a study in the United States found that Hispanic and Black patients with CF had worse respiratory function compared to white patients [5]. We therefore propose that future studies should include ethnicity as a patient demographic. Further research into the impact of ethnicity on CFBD will enable a more inclusive and holistic approach towards diagnosis and treatment of CF.

Author contributions

All authors made an equal contribution to the final piece, both during analysis of the original document and writing the final response. All authors have read and revised the final piece. All authors accept full responsibility for the produced document.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  5 in total

1.  Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study.

Authors:  Jeetesh V Patel; Julia Chackathayil; Elizabeth A Hughes; Craig Webster; Gregory Y H Lip; Paramjit S Gill
Journal:  Int J Cardiol       Date:  2012-11-07       Impact factor: 4.164

Review 2.  Cystic fibrosis-related bone disease: insights into a growing problem.

Authors:  Michael S Stalvey; Gregory A Clines
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-12       Impact factor: 3.243

Review 3.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

4.  Bone accrual and structural changes over one year in youth with cystic fibrosis.

Authors:  Rosara M Bass; Babette S Zemel; Virginia A Stallings; Mary B Leonard; Jaime Tsao; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2022-03-25

5.  Prevalence of Vitamin D Deficiency and Associated Risk Factors in the US Population (2011-2012).

Authors:  Naveen R Parva; Satish Tadepalli; Pratiksha Singh; Andrew Qian; Rajat Joshi; Hyndavi Kandala; Vinod K Nookala; Pramil Cheriyath
Journal:  Cureus       Date:  2018-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.